Search results
Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoNektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics...
Against Sunscreen Absolutism
The Atlantic· 4 days agoThe country’s predominantly white population has by far the world’s highest rate of skin cancer, and for years the public-health establishment has warned...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 7 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Q1 2024 Nektar Therapeutics Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoAdditionally, REZPEG was well-tolerated and treatment with REZPEG did not induce anti-drug antibodies in patients, which has been reported with some examples in the IL-2 mutein ...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 6 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Protagonist Therapeutics to Participate in the Citizens JMP Life Sciences Conference and the Capital...
Digital Journal· 7 days agoCapital One 1st Annual Biotech/Biopharma Disruptors Event - May 14, 2024 Panel: New Potential Dermatology Treatments for Psoriasis, Urticaria, & Alopecia ...
The hell of drug pricing boards
Maryland Matters via Yahoo News· 5 days agoJames K. Glassman, the well-known economist whose clients have included pharmaceutical companies, makes the case against prescription drug affordability boards. The post The hell of drug pricing boards appeared first on Maryland Matters.
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
ETF DAILY NEWS· 3 days agoStockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Wednesday morning. The brokerage issued a hold rating on the stock. Can-Fite ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoSTRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the
Want Tighter, Firmer Skin Over 40? Doctors Recommend These 3 Hydrating Serums For A Supple...
SheFinds via Yahoo News· 4 days agoEnhancing your skincare regimen with a serum is a smart move that can provide impressive results....